Drug data last refreshed 4m ago · AI intelligence enriched 2w ago
LIPOSYN II 10% is an intravenous lipid emulsion containing safflower oil and soybean oil used as a parenteral nutrition source. It provides essential fatty acids and calories to patients unable to receive adequate nutrition orally or enterally. The product works by delivering lipid-based nutrition directly into the bloodstream for metabolic utilization.
As an aging parenteral nutrition product approaching loss of exclusivity with moderate competitive pressure, brand teams are likely managing defensive strategies rather than growth initiatives.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on LIPOSYN II offers exposure to hospital-based commercial operations and institutional sales strategies, but limited career trajectory given the product's mature lifecycle and minimal linked job openings. This role is best suited for professionals seeking stable, specialized expertise in parenteral nutrition markets rather than high-growth career advancement.
Worked on LIPOSYN II 10% at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.